
Company Info
Phone(212) 847-6204
Year Established
2014
Ticker
ROIV
Exchange
NASDAQ
Contacts
Matthew GlineCEO
Amy Mahery
CCO
Srini Ramanathan, PhD
CDO
Richard Pulik
CFO
Jo Chen
General Counsel
Eric Venker
President & COO
Company Description
Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch Vants -nimble and focused biopharmaceutical and health technology companies.